Artificial Intelligence in Precision Pharmacotherapy
Optimizing Drug Selection and Dosing in Chronic Diseases
Keywords:
artificial intelligence, chronic diseases, pharmacotherapy, AI driven software, dosing selectionAbstract
Chronic disease is one of the major causes of death worldwide which generally not vaccine preventable are also don’t resolve spontaneously. The world health organization identifies four main types of chronic diseases including cardiovascular diseases (CVD, primarily heart disease and stroke), Cancer, chronic respiratory diseases and diabetes which are responsible for the majority of related deaths, while they can be treated, are seldom healed with medicine or other medical treatment. Chronic disease care is becoming increasingly confined, which frequently results in suboptimal therapeutic efficacy and adverse medication reactions. Pharmacotherapy involve in management and treatment of chronic diseases mainly associate with the dose and drug selection for the authorized treatment that significantly impact on outcomes. Artificial intelligence and machine learning are shifting pharmacotherapy from a reactive, standardize model to proactive personalized and data driven. Different AI driven software’s and technical platform along with their superiority in management of chronic diseases has elaborate in this review article. This article looks at the use of Artificial intelligence to optimize medicine selection and dosing for complicated, long-term illness. Apart from their promising outcomes, concern about mainly data privacy, model interpretability and also ethical regulatory barriers remain. This study explores the challenges emphasizing the significant importance of transparent, explainable AI in ensuring efficacy and safety in clinical practices. The use of AI in precision pharmacology has the potential to greatly improve therapeutic results, patient compliance and healthcare resource use for chronic conditions.
Downloads
References
Deb, T., Das, A., Ojha, B., & Das, P. (2024). Ensuring safe and effective pharmacotherapy: The role of "community pharmacology" in attaining "health for all" from the Indian perspective. Journal of family medicine and primary care, 13(12), 5465–5471. https://doi.org/10.4103/jfmpc.jfmpc_1226_24.
Hacker, K. (2024). The burden of chronic disease. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 8(1), 112-119. https://doi.org/10.1016/j.mayocpiqo.2023.08.005.
Global Burden of Disease Collaborative Network, Global Burden of Disease Study 2021 (GBD 2021) Results (2024, Institute for Health Metrics and Evaluation – IHME) https://vizhub.healthdata.org/gbd-resuls.
Derek Yach et al., Global Chronic Diseases.Science307, 317-317(2005).DOI: https://10.1126/science.1108656.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020 (https://gco.iarc.fr/today. accessed February 2021).
Alleynea, G., Evansb, T., Irwinc, A., Jhad, P., & Veillarde, J. Enhancing Human Capital and Boosting Productivity by Tackling Non-Communicable Diseases.2018
Gettman, D. Integrating Pharmacokinetics/Pharmacodynamics (PK/PD) with Artificial Intelligence to Advance Predictive Modeling of Therapeutic Windows.
Religioni, U., Barrios-Rodríguez, R., Requena, P., Borowska, M., & Ostrowski, J. (2025). Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life. Medicina (Kaunas, Lithuania), 61(1), 153. https://doi.org/10.3390/medicina61010153.
Minichmayr, I. K., Dreesen, E., Centanni, M., Wang, Z., Hoffert, Y., Friberg, L. E., et al. (2024). Model-informed precision dosing: state of the art and future perspectives. Advanced drug delivery reviews, 215, 115421.
Moke, E. G., Demaki, W. E., Daubry, T. M. E., Ataikiru, O. M., Agbonifo-Chijiokwu, E., Ofulue, O.et al. (2023). Coexistence of hypertension with diabetes mellitus and its pharmacotherapy. Scientia Africana, 22(2), 135-154.
Gao, M., Lin, W., Ma, T., Luo, Y., Xie, H., Cheng, X., & Bai, Y. (2022). The Impact of Different Antihypertensive Drugs on Cardiovascular Risk in Isolated Systolic Hypertension with Type 2 Diabetes Patients. Journal of clinical medicine, 11(21), 6486. https://doi.org/10.3390/jcm11216486.
Pagès-Puigdemont, N., Mangues, M. A., Masip, M., Gabriele, G., Fernández-Maldonado, L.,et al.(2016). Patients' Perspective of Medication Adherence in Chronic Conditions: A Qualitative Study. Advances in therapy, 33(10), 1740–1754. https://doi.org/10.1007/s12325-016-0394-6.
Coleman, C. I., Limone, B., Sobieraj, D. M., Lee, S., Roberts, M. S., Kaur, et al..,(2012). Dosing frequency and medication adherence in chronic disease. Journal of managed care pharmacy, 18(7), 527-539.
Hisashige A. (2012). The effectiveness and efficiency of disease management programs for patients with chronic diseases. Global journal of health science, 5(2), 27–48. https://doi.org/10.5539/gjhs.v5n2p27.
Dizet, S., Haffen, E., & Javelot, H. (2025). Adherence to evidence-based treatment guidelines for depression: a systematic review. BMC psychiatry, 25(1), 825. https://doi.org/10.1186/s12888-025-07192-6.
Caffrey, A. R., & Borrelli, E. P. (2021). The art and science of drug titration. Therapeutic advances in drug safety, 11, 2042098620958910. https://doi.org/10.1177/2042098620958910.
Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A., & Sakharkar, M. K. (2016). Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomarker insights, 11, 95–104. https://doi.org/10.4137/BMI.S38440.
Wang, W., Ferrari, D., Haddon-Hill, G., & Curcin, V. (2023). Electronic health records as source of research data. Machine Learning for Brain Disorders, 331-354.
Bennett, C. C., Doub, T. W., & Selove, R. (2012). EHRs connect research and practice: Where predictive modeling, artificial intelligence, and clinical decision support intersect. Health Policy and Technology, 1(2), 105-114.
Daly, A. B., Boughton, C. K., Nwokolo, M., Hartnell, S., Wilinska, M. E., Cezar, A.,et al,.(2023). Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial. Nature medicine, 29(1), 203-208.
Malviya, R., Kaushik, N., Rai, T., Saraswathy, M. P., & Awasthi, R. (2025). Machine Learning in Healthcare: Advances and Future Prospects. Apple Academic Press.
Topalovic, M., Das, N., Burgel, P. R., Daenen, M., Derom, E., Haenebalcke, C.,et al,.(2019). Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. European Respiratory Journal, 53(4).
Momtazmanesh, S., Nowroozi, A., & Rezaei, N. (2022). Artificial intelligence in rheumatoid arthritis: current status and future perspectives: a state-of-the-art review. Rheumatology and therapy, 9(5), 1249-1304.
Nasser, A., Michalczak, M., Żądło, A., & Tokarek, T. (2025). AI-Powered Precision: Revolutionizing Atrial Fibrillation Detection with Electrocardiograms. Journal of Clinical Medicine, 14(14), 4924. https://doi.org/10.3390/jcm14144924.
Li, J., Hu, J., Yang, Y., Zhang, H., Liu, Y., Fang, Y., Qu, L., Lin, A., Luo, P.,et al.. (2025). Drug resistance in cancer: molecular mechanisms and emerging treatment strategies. Molecular biomedicine, 6(1), 111. https://doi.org/10.1186/s43556-025-00352-w.
Matsuki, Y., Kozima, Y., Yanagi, M., Sako, K. I., Watanabe, T., Yasuno, N.,et al,.(2025). Vancomycin dosing design method considering risk factors for nephrotoxicity. Journal of pharmaceutical health care and sciences, 11(1), 14. https://doi.org/10.1186/s40780-025-00416-7.
Patocka, J., Nepovimova, E., Wu, W., & Kuca, K. (2020). Digoxin: Pharmacology and toxicology—A review. Environmental toxicology and pharmacology, 79, 103400.
Bansal, Shyam Bihari,*. Therapeutic Drug Monitoring of Tacrolimus in Kidney Transplantation. Indian Journal of Transplantation 14(1):p 8-14, Jan–Mar 2020. | DOI: https://10.4103/ijot.ijot_4_20.
Wojtczak, D., Kasznicki, J., & Drzewoski, J. (2017). Pros and cons of polypharmacy in elderly patients with diabetes. Clinical Diabetology, 6(1), 34-38.
Pirmohamed, M. (2023). Pharmacogenomics: current status and future perspectives. Nature Reviews Genetics, 24(6), 350-362.
Gu W, Shao Q, Jiang L. Predicting Pharmacokinetics of Drugs in Patients with Heart Failure and Optimizing Their Dosing Strategies Using a Physiologically Based Pharmacokinetic Model. Pharmaceutics. 2025; 17(11):1394. https://doi.org/10.3390/pharmaceutics17111394.
Alum, E. U., & Ugwu, O. P. C. (2025). Artificial intelligence in personalized medicine: transforming diagnosis and treatment. Discover Applied Sciences, 7(3), 193.
Harishbhai Tilala, M., Kumar Chenchala, P., Choppadandi, A., Kaur, J., Naguri, S., Saoji,et al,.(2024). Ethical Considerations in the Use of Artificial Intelligence and Machine Learning in Health Care: A Comprehensive Review. Cureus, 16(6), e62443. https://doi.org/10.7759/cureus.62443.
Tong, L., Shi, W., Isgut, M., Zhong, Y., Lais, P., Gloster, L.,et al.,(2023). Integrating multi-omics data with EHR for precision medicine using advanced artificial intelligence. IEEE Reviews in Biomedical Engineering, 17, 80-97.
Vasey, B., Novak, A., Ather, S., Ibrahim, M., & McCulloch, P. (2023). DECIDE-AI: a new reporting guideline and its relevance to artificial intelligence studies in radiology. Clinical Radiology, 78(2), 130-136.
Mennella, C., Maniscalco, U., De Pietro, G., & Esposito, M. (2024). Ethical and regulatory challenges of AI technologies in healthcare: A narrative review. Heliyon, 10(4).
De Guio, F., Rienstra, M., Lillo-Castellano, J. M., Toribio-Fernández, R., Lizcano, C.,et al,.(2025). Enhanced detection of atrial fibrillation in single-lead electrocardiograms using a Cloud-based artificial intelligence platform. Heart Rhythm, 22(7), 1667-1674.
Ul Rehman, S., Tarek, N., Magdy, C., Kamel, M., Abdelhalim, M., Melek, A.,et al,. (2024). AI-based tool for early detection of Alzheimer's disease. Heliyon, 10(8), e29375. https://doi.org/10.1016/j.heliyon.2024.e29375.
ILYAS, G. (2025). Predicting Chronic Kidney Disease: A Machine Learning Approach to Early Detection and Risk Assessment.
Niraula, P., Upreti, M., Kadariya, S., Poudel, B., Kadariya, S., & Kunwar, S. (2025). AI/ML driven prediction of COPD exacerbations and readmissions: a systematic review and meta-analysis. Frontiers in Digital Health, 7, 1641356.
Plass, M., Olteanu, G. E., Dacic, S., Kern, I., Zacharias, M., Popper, H., Fukuoka, J., Ishijima, S., Kargl, et al,.(2025). Comparative performance of PD-L1 scoring by pathologists and AI algorithms. Histopathology, 87(1), 90–100. https://doi.org/10.1111/his.15432’
Nelson, J. (2024). AI-assisted chronic disease management: Real-time interventions.
Ngcobo N. N. (2025). Silent Dangers in Elderly Pharmacotherapy: The Interplay of Polypharmacy, Multimorbidity, and Drug Interactions. Journal of evaluation in clinical practice, 31(7), e70283. https://doi.org/10.1111/jep.70283.
Du, Y., Yang, P., Liu, Y., Deng, C., & Li, X. (2025). Artificial intelligence in chronic disease self-management: current applications and future directions. Frontiers in Public Health, 13, 1689911.
Zack, M., Stupichev, D. N., Moore, A. J., Slobodchikov, I. D., Sokolov, D. G., Trifonov, I. F., & Gobbs, A. (2025). Artificial Intelligence and Multi-Omics in Pharmacogenomics: A New Era of Precision Medicine. Mayo Clinic proceedings. Digital health, 3(3), 100246. https://doi.org/10.1016/j.mcpdig.2025.100246.
Chen, E., Prakash, S., Janapa Reddi, V., Kim, D., & Rajpurkar, P. (2025). A framework for integrating artificial intelligence for clinical care with continuous therapeutic monitoring. Nature biomedical engineering, 9(4), 445-454.
Johnson, K. B., Wei, W. Q., Weeraratne, D., Frisse, M. E., Misulis, K., Rhee, K.,et al. (2021). Precision medicine, AI, and the future of personalized health care. Clinical and translational science, 14(1), 86-93.
Mennella, C., Maniscalco, U., De Pietro, G., & Esposito, M. (2024). Ethical and regulatory challenges of AI technologies in healthcare: A narrative review. Heliyon, 10(4). https://doi.org/10.1016/j.heliyon.2024.e26297.
Bringhurst, K., Jones, T., Runko, G., Jabbari, M., Zipparro, N., Nghi Vo, G., Ullah, A.,et al.(2025). Artificial Intelligence in the Management of Polypharmacy Among Older Adults: A Scoping Review. Cureus, 17(8), e90867. https://doi.org/10.7759/cureus.90867.
Cate, M. (2025). Integration of AI and Predictive Analytics to Optimize SGLT2 Inhibitor Prescription in High-Risk Patients.
Braga, D. M., & Rawal, B. (2025). Harnessing AI and Quantum Computing for Revolutionizing Drug Discovery and Approval Processes: Case Example for Collagen Toxicity. JMIR bioinformatics and biotechnology, 6, e69800. https://doi.org/10.2196/69800.
Downloads
-
Download PDF
Abstract Views: 51, 
Download PDF: 27
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Inventum Biologicum: An International Journal of Biological Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
